Duke logo

Patient Preferences: PARPi vs Standard Chemo - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn which medicine that women diagnosed with ovarian, fallopian tube, or peritoneal cancer prefer to take.

What is the Condition Being Studied?

Ovarian, Fallopian Tube, or Peritoneal Cancer

Who Can Participate in the Study?

Adult women who:
- Have been diagnosed with ovarian, fallopian tube, or peritoneal cancer
- Have gotten chemotherapy treatment

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
-Complete a survey about new medication treatment such as side effects, costs, and the chances that the medication will work at different times during treatment

Study Details

Full Title
Preferences of Women with Ovarian Cancer for Aspects of Treatment with a PARP Inhibitor versus Standard Chemotherapy
Principal Investigator
Gynecologic Cancers Specialist
Protocol Number
IRB:PRO00089531
Phase
Phase N/A
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698